A simplified MRI‑based risk score and nomogram to predict initial objective response in unresectable hepatocellular carcinoma treated with HAIC, targeted therapy, and immunotherapy: a multicenter study.

Integrated model of MRI biomarkers and clinical factors for predicting pathologic response after neoadjuvant chemoradiotherapy in locally advanced rectal cancer.

Development and validation of a preoperative 18F-PSMA-1007 PET/MR prognostic model for predicting biochemical recurrence in prostate cancer: a multicentre study.

Preoperative magnetic resonance imaging-based nomogram for predicting overall survival in patients with glioma: a multicenter study.

BACKGROUND Glioma prognostication relies on histopathological and molecular assessment requiring tissue sampling. Accessible tools for noninvasive preoperative prognostication remain limited. METHODS This multicenter retrospective study included 1992 patients (1207 in the training dataset [TD] and 785 in the external...

Baseline multiparametric MRI combined with clinical factors for predicting pathological complete response of breast cancer after Neoadjuvant chemotherapy.

PURPOSE Early prediction of response to neoadjuvant chemotherapy (NAC) may facilitate treatment stratification in breast cancer. This study aimed to evaluate the association of baseline virtual magnetic resonance elastography (vMRE) and intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI) parameters with...

Early recurrence predicts survival in patients with 10 or more bilobar colorectal liver metastases: A LASSO regression-based nomogram model.

INTRODUCTION Parenchymal-sparing one-stage hepatectomy (POSH) has expanded surgical eligibility for patients with high-burden (≥10) colorectal liver metastases (CLM). Early recurrence (ER), defined as recurrence within 6 months, remains a challenge, and its prognostic significance and preoperative predictability in thi...

Prediction of the Efficacy of PA-TACE in Patients with Clearly Defined Hepatocellular Carcinoma by Imaging Combined with Serology: A Retrospective Cohort Study with a Two-Center Follow-Up of up to 12 Years.

OBJECTIVE The purpose of this study was to determine which patients with hepatocellular carcinoma (HCC) actually benefit from Postoperative adjuvant Transarterial chemoembolization (PA-TACE) and to develop a reliable predictive model for tailored treatment choices. METHODS A total of 150 HCC patients received PA-TACE...